CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 123 filers reported holding CLOVIS ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $14,181,000 | +54.1% | 953,711 | +157.2% | 0.30% | +37.2% |
| Q1 2019 | $9,204,000 | -49.0% | 370,840 | -63.1% | 0.22% | -49.2% |
| Q4 2018 | $18,054,000 | +11.0% | 1,005,237 | +226.2% | 0.43% | +20.2% |
| Q1 2018 | $16,269,000 | -65.0% | 308,119 | -55.0% | 0.36% | -66.5% |
| Q4 2017 | $46,548,000 | +8.1% | 684,536 | +31.1% | 1.07% | -1.9% |
| Q3 2017 | $43,041,000 | -19.0% | 522,345 | -8.0% | 1.09% | -16.2% |
| Q2 2017 | $53,154,000 | +240.9% | 567,700 | +131.8% | 1.30% | +258.6% |
| Q1 2017 | $15,593,000 | -61.2% | 244,900 | -72.9% | 0.36% | -60.2% |
| Q4 2016 | $40,147,000 | +110.1% | 903,800 | +70.6% | 0.91% | +100.0% |
| Q3 2016 | $19,104,000 | +105.2% | 529,911 | -21.9% | 0.46% | +105.0% |
| Q2 2016 | $9,308,000 | – | 678,410 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |